Ovarian cancer treatment with PARP inhibitors after recurrence
After chemo for recurrent ovarian cancer, oral maintenance therapy with an inhibitor of poly (ADP-ribose) polymerase (PARP) has shown benefits in women with platinum-sensitive ovarian cancer. According to a recent research review publication, the advantage of this special treatment was specifically obvious in patients with the BRCA mutation. BRCA anomalies can be considered either a […]
This post Ovarian cancer treatment with PARP inhibitors after recurrence first appeared on Gynecologic Oncology Institute | Robotic Surgery | Integrative Healing and is written by Dr Steve Vasilev MD
from Gynecologic Oncology Institute | Robotic Surgery | Integrative Healing https://www.gynecologiconcologyinstitute.org/news/ovarian-cancer/survival/ovarian-cancer-treatment-with-parp-inhibitors-after-recurrence/
via Gynecologic Oncology Institute
Comments
Post a Comment